A Clinical study to compare the effects of Ayurvedic drug Guggulu Rasayan over another Ayurvedic drug Vidangadi Loha with Honey water in Dyslipidemia (Medoroga)

A Randomized comparative Clinical Study to evaluate the efficacy of Guggulu Rasayana over Vidangadi Loha with Madhudaka in the Management of Medoroga with special reference to Dyslipidemia - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066337

Enrollment

120

Registered

2024-04-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Having clinical features of Dyslipidemia and Medoroga 2. Serum lipid levels ranging Serum Cholesterol (201mg/dl or more) Serum Triglycerides (161mg/dl or more) Serum HDL (below 41mg/dl Serum LDL (131mg/dl or more) Serum VLDL (41mg/dl or more) All or any of these. 3. Patients between the ages from 20-60 years of either sex

Exclusion criteria

Exclusion criteria: 1. Patients having Cardiac problem 2. Patients suffering with serious metabolic disorders like Diabetes Mellitus and HTN. 3. Pregnancy and Lactating Women.

Design outcomes

Primary

Measure	Time frame
Reduction in the parameters of Lipid profileTimepoint: After 60 days	—

Secondary

Measure	Time frame
Prevention of Lifestyle disorders like Obeysity, Atherosclerosis, Cardiac AttacksTimepoint: After 120 days	—

Countries

India

Contacts

Public ContactDr Namita Minajagi

BVVS Ayurved Medical College and Hospital, Bagalkot

minajiginamita@gmail.com9739085906

Outcome results